Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
yiqihuoxuetongqiaomingmu
- Development stage
- Unknown
- Lead developer
- First Affiliated Hospital of Guangzhou University of Chinese Medicine
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Yiqihuoxuetongqiaomingmu is a Traditional Chinese Medicine (TCM) formula developed by the First Affiliated Hospital of Guangzhou University of Chinese Medicine for the treatment of non-arteritic ischemic optic neuropathy (NAION). The formula is designed based on the TCM principles of supplementing Qi, activating blood circulation to resolve stasis, and opening the orifices to improve vision. Its therapeutic mechanism involves improving microcirculation in the optic nerve head, reducing edema, and providing neuroprotection to retinal ganglion cells. Clinical research conducted at the developing institution has demonstrated its potential in improving visual acuity and visual field sensitivity in patients suffering from the acute and convalescent stages of NAION. It is typically administered as an oral decoction or granule preparation.
- Other names
- Yiqi Huoxue Tongqiao Mingmu decoctionYiqi Huoxue Tongqiao Mingmu formula
Beyond the preview
Go deeper on yiqihuoxuetongqiaomingmu.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on yiqihuoxuetongqiaomingmu.